Market Overview

Columbia Laboratories Announces Amended Class Action Lawsuit Dismissed without Prejudice

Columbia Laboratories (NASDAQ: CBRX) announced Wednesday that the
previously disclosed Consolidated Second Amended Class Action Complaint
to the putative class action lawsuit filed against the Company, Actavis,
Inc. and certain officers of both companies (the “Defendants”) in the
United States District Court, District of New Jersey, entitled In re
Columbia Laboratories, Inc., Securities Litigation, has been
dismissed. The court ruled that changes the plaintiffs made to their
first amended complaint “still do not create a strong inference that
[Columbia] acted with an intent to deceive, manipulate or defraud.” The
court ordered that if the plaintiffs sought to attempt to plead a
cognizable action for a third time, they must do so within thirty days
and specifically address why the attempt would not

See full press release

Posted-In: News Guidance Contracts FDA Legal Management Global

 

Related Articles (CBRX + ACT)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters